​

Korsana Biosciences (KRSA) Revenue & Revenue Breakdown

OverviewFinancialsChart

Korsana Biosciences Revenue Highlights

Latest Revenue (Y)

$2.07M

0

Main Segment (Y)

License Agreement

Korsana Biosciences Revenue by Period

Korsana Biosciences Revenue by Year

DateRevenueChange
2025-12-31$2.07M3.70%
2024-12-31$2.00M100.00%
2023-12-31--100.00%
2022-12-31$297.00K-91.05%
2021-12-31$3.32M44.60%
2020-12-31$2.30M-49.06%
2019-12-31$4.51M100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--

Korsana Biosciences generated $2.07M in revenue during NA 2025, up 3.70% compared to the previous quarter, and up 90.33% compared to the same period a year ago.

Korsana Biosciences Revenue by Quarter

DateRevenueChange
2026-06-30-100.00%
2026-03-31--100.00%
2025-12-31$1.02M17.14%
2025-09-30$875.00K840.86%
2025-06-30$93.00K14.81%
2025-03-31$81.00K-95.51%
2024-12-31$1.81M830.93%
2024-09-30$194.00K100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30--100.00%
2022-06-30$306.00K-56.96%
2022-03-31$711.00K33.40%
2021-12-31$533.00K53.16%
2021-09-30$348.00K-88.40%
2021-06-30$3.00M4738.71%
2021-03-31$62.00K-53.38%
2020-12-31$133.00K-66.75%
2020-09-30$400.00K-46.60%
2020-06-30$749.00K-26.13%
2020-03-31$1.01M-31.53%
2019-12-31$1.48M5.94%
2019-09-30$1.40M-14.13%
2019-06-30$1.63M100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30--

Korsana Biosciences generated - in revenue during Q2 2026, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Korsana Biosciences Revenue Breakdown

Korsana Biosciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
License Agreement$1.75M
License$250.00K

Korsana Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 24: License Agreement (87.50%), and License (12.50%).

Korsana Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
KRSAKorsana Biosciences$2.07M-
ADXNAddex Therapeutics$1.61M$235.00K
RADXRadiopharm Theranostics$299.23K$1.36M
TCRTAlaunos Therapeutics$5.00K-
XTLBXTL Biopharmaceuticals--
PLRZPolyrizon--
QNRXQuoin Pharmaceuticals--
KTTAPasithea Therapeutics--

KRSA Revenue FAQ

What is Korsana Biosciences’s yearly revenue?

Korsana Biosciences's yearly revenue for 2025 was $2.07M, representing an increase of 3.70% compared to 2024. The company's yearly revenue for 2024 was $2M, representing an increase of 100.00% compared to 2023. KRSA's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022.

What is Korsana Biosciences’s quarterly revenue?

Korsana Biosciences's quarterly revenue for Q2 2026 was $0, a 100.00% increase from the previous quarter (Q1 2026), and a -100.00% decrease year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $0, a -100.00% decrease from the previous quarter (Q4 2025), and a -100.00% decrease year-over-year (Q1 2025). KRSA's quarterly revenue for Q4 2025 was $1.02M, a 17.14% increase from the previous quarter (Q3 2025), and a -43.24% decrease year-over-year (Q4 2024).

What is Korsana Biosciences’s revenue growth rate?

Korsana Biosciences's revenue growth rate for the last 3 years (2023-2025) was 0%, and for the last 5 years (2021-2025) was -37.53%.

What are Korsana Biosciences’s revenue streams?

Korsana Biosciences's revenue streams in c 24 are License Agreement, and License. License Agreement generated $1.75M in revenue, accounting 87.50% of the company's total revenue License generated $250K in revenue, accounting 12.50% of the company's total revenue

What is Korsana Biosciences’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Korsana Biosciences was License Agreement. This segment made a revenue of $1.75M, representing 87.50% of the company's total revenue.